Search Results - "ESTRADA, DORIS E."

The effects of prebiotics on gastrointestinal side effects of metformin in youth: A pilot randomized control trial in youth-onset type 2 diabetes by Dixon, Sydney A, Mishra, Sidharth, Dietsche, Katrina B, Jain, Shalini, Mabundo, Lilian, Stagliano, Michael, Krenek, Andrea, Courville, Amber, Yang, Shanna, Turner, Sara A, Meyers, Abby G, Estrada, Doris E, Yadav, Hariom, Chung, Stephanie T

“…Dr. Yadav is Chief Scientific Officer and Co-Founder of Postbiotics Inc and has no conflict of interest with this work. All other authors have no conflicts of…”
Get full text

Reevaluating First-line Therapies in Youth-Onset Type 2 Diabetes by Chung, Stephanie T, Davis, Faith, Patel, Tejal, Mabundo, Lilian, Estrada, Doris E

“…Abstract The prevalence of youth-onset type 2 diabetes is growing worldwide and current first-line treatment with metformin and intensive behavior and…”
Get full text

15-OR: The COVID-19 Pandemic and New-Onset Pediatric Type 2 Diabetes by MARKS, BRYNN E., KHILNANI, ANEKA, MEYERS, ABBY, ESTRADA, DORIS E., BOUGHTON, JENNIFER, GAI, JIAXIANG, STREISAND, RANDI, MONAGHAN, MAUREEN

“…Introduction: Reports are emerging about the impact of the COVID-19 pandemic on pediatric T1D, however few studies have explored pediatric T2D. We aimed to…”
Get full text

990-P: Prebiotics and Metformin: A Pilot Randomized Controlled Trial in Youth-Onset Type 2 Diabetes by DIXON, SYDNEY A., MEYERS, ABBY, TUTTLE, KUNANI, MABUNDO, LILIAN, STAGLIANO, MICHAEL S., VILLALOBOS-PEREZ, ALFREDO, DIETSCHE, KATRINA B., COURVILLE, AMBER B., ESTRADA, DORIS E., CHUNG, STEPHANIE T.

“…Metformin is the only first-line oral agent for youth with type 2 diabetes mellitus (Y-T2D) , but efficacy and adherence is complicated by gastrointestinal…”
Get full text

991-P: Metformin Plasma Concentration as a Biomarker of Treatment Responsiveness in Youth-Onset Type 2 Diabetes by DIETSCHE, KATRINA B., ZENNO, ANNA, VILLALOBOS-PEREZ, ALFREDO, DIXON, SYDNEY A., STAGLIANO, MICHAEL S., MABUNDO, LILIAN, SHOUPPE, EILEEN L., ESTRADA, DORIS E., MEYERS, ABBY, COGEN, FRAN R., WALTER, MARY, WALTER, PETER, CHUNG, STEPHANIE T.

“…Metformin is the first-line therapy for youth-onset type 2 diabetes mellitus (Y-T2D) but is suboptimal in up to 50% of youth. The reasons for increased failure…”
Get full text

Mindfulness-based intervention for depression and insulin resistance in adolescents: Protocol for BREATHE, a multisite, pilot and feasibility randomized controlled trial by Sanchez, Natalia, Chen, Michele, Ho, Sally, Spinner, Holly, Vagadori, Jack, Neiser, Abigail, Padilla, Kimberly, Bristol, Madison, Winfield, Elijah, Thorstad, Isabel, Gulley, Lauren D., Lucas-Thompson, Rachel G., Pyle, Laura, Thompson, Talia, Estrada, Doris E., Basch, Molly, Tanofsky-Kraff, Marian, Kelsey, Megan M., Mackey, Eleanor R., Shomaker, Lauren B.

“…Elevated depression symptoms have been associated with higher insulin resistance in adolescents, and consequently, greater risk for type 2 diabetes (T2D)…”
Get full text

1160-P: Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes-Interim Results from Pilot Randomized Controlled 12-Week Trial by Patel, Tejal, Estrada, Doris E, Meyers, Abby, Mackey, Eleanor, Chung, Stephanie T

“…Introduction: Continuous glucose monitors (CGM) may improve diabetes self-management in youth-onset type 2 diabetes (Y-T2D), but feasibility in Y-T2D on…”
Get full text